Magnesium sulfate and brain in preeclampsia

Authors

  • Rommel Lacunza-Paredes Médico Gineco-Obstetra, Unidad de Medicina Materno Fetal, Hospital Nacional Daniel Alcides Carrión, Callao, Perú
  • Fernanda Santis-Moya Médico residente de la especialidad de Gineco-Obstetricia, Unidad de Medicina Materno Fetal, Hospital Nacional Daniel Alcides Carrión, Callao, Perú

DOI:

https://doi.org/10.31403/rpgo.v63i1991

Abstract

Magnesium sulfate is the drug of choice in the prophylaxis and treatment of eclampsia. The recent understanding of the neurological manifestations within the reversible posterior leukoencephalopathy produced by preeclampsia has confirmed mechanisms that had been previously based on animal studies, thus adding value to this old drug. From the MAGPIE study to this day, many questions regarding the use of magnesium sulfate in preeclampsia remain ulsolved, but its value as a first-line treatment for brain manifestations in preeclampsia is undoubtedly high.

Downloads

Download data is not yet available.

Published

2017-07-11

How to Cite

Lacunza-Paredes, R., & Santis-Moya, F. (2017). Magnesium sulfate and brain in preeclampsia. The Peruvian Journal of Gynecology and Obstetrics, 63(2), 235–240. https://doi.org/10.31403/rpgo.v63i1991

Issue

Section

Simposio

Most read articles by the same author(s)